5-amino-1mq third party tested Peptide 5-Amino-1MQ – True Lab Peptides

Clinical trials and reports from individuals suggest AOD 9604 therapy has minimal to no significant side effects for most

This is significant for increasing B12 levels in individuals unable to absorb B12 from food or supplements due to their bodys condition

Common side effects include, but may not be limited to: pain or redness at the injection site mild diarrhea pruritus (itching) increased swelling joint pain dizziness headache nervousness or anxiety Serious side effects may include: allergic reactions peripheral vascular thrombosis hypokalemia (low potassium levels) pulmonary edema (fluid build-up around or in the lungs) thrombocytosis congestive heart failure There have been reports of anaphylactic shock and death after the parenteral administration of vitamin B12

Peptides such as AOD-9604 have been developed to explore signalling pathways and receptor interactions in controlled laboratory environments

Therefore, high plasma concentrations of vitamin B12 were more common shortly (1 year) before the diagnosis of cancer, but less common when measured at earlier time points before the diagnosis of cancer